VivoSim Labs, Inc. (NasdaqCM: VIVS)
Health Care · Biotechnology · US
$0.16
-12.88% today · -93.7% 1Y
VivoSim Labs, Inc. (NasdaqCM: VIVS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.60M and employs 15 people.
Over the last twelve months the share price has lost 93.7%, trading between 0.15 and 3.40.
Tweenvest scores VivoSim Labs, Inc. across four factors: quality 29/100, value 41/100. Its strongest factor is value.
VIVS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.60M
- Revenue (TTM)
- $112.00K
- P/E
- —
- EPS
- -3.77
- Dividend yield
- —
- Beta (5Y)
- 1.49
- 52-week high
- $3.40
- 52-week low
- $0.15
- Avg volume (3M)
- —
- Shares outstanding
- 16.59M
- Employees
- 15
- Next earnings
- —
About VivoSim Labs, Inc.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
- ISIN
- US68620A3023
- Founded
- 2007
- Listed since
- Feb 14, 2012
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Modus Therapeutics Holding AB (publ)OM: MODTX | $2.76M | Skr0.18 | -52.45% |
| Vaccinex, Inc.OTCPK: VCNX | $2.69M | $1.01 | -11.81% |
| Bioxytran, Inc.OTCPK: BIXT | $2.67M | $0.02 | +1.75% |
| Spermosens AB (publ)NGM: SPERM | $2.67M | Skr— | — |
| ExpreS2ion Biotech Holding AB (publ)OM: EXPRS2 | $2.47M | Skr1.03 | -5.50% |
| Ocean Sciences LtdASX: OSS | $2.46M | AU$0.02 | +15.38% |
| Enzolytics, Inc.OTCPK: ENZC | $2.42M | $0.00 | +11.11% |
| Mosaic ImmunoEngineering, Inc.OTCPK: CPMV | $2.41M | $0.33 | +215.04% |
Figures last refreshed Oct 18, 2026.